ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Cetrorelix
C70H92ClN17O14
1431 g/mol
APIDanger

Cetrorelix

CAS120287-85-6
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

Cetrorelix is a synthetic decapeptide compound used as an active pharmaceutical ingredient in pharmaceutical manufacturing. It is characterized by a high molecular weight and a complex structure with multiple amide bonds and aromatic rings, reflecting its role as a peptide-based pharmaceutical intermediate.

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Cetrorelix?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongSame Parent

Cetrorelix acetate

CAS130143-01-0

pharmaceutical raw material

StrongSame Parent

Cetrotide

CAS145672-81-7

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.84

Ganirelix

CAS123246-29-7

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.84

Ganirelix

CAS124904-93-4

pharmaceutical raw material

ReferenceSame Category

Biapenem

CAS120410-24-4

pharmaceutical raw material

ReferenceSame Category

Icotinib hydrochloride

CAS1204313-51-8

pharmaceutical raw material

ReferenceSame Category

Samidorphan L-malate

CAS1204592-75-5

pharmaceutical raw material

ReferenceSame Category

Zotiraciclib

CAS1204918-72-8

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Harmful
Harmful
Health Hazard
Health Hazard
Danger
H360May damage fertility or the unborn child
H319Causes serious eye irritation

Customs Tariff Classification

The international HS code for Cetrorelix (CAS 120287-85-6) is 2937.19.

HS code (international, 6-digit)

2937.19

EU CN code (8-digit)

2937 19 00

Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.

Identifiers
IUPAC Name

(2S)-1-[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-acetamido-3-naphthalen-2-ylpropanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]-3-pyridin-3-ylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]-4-methylpentanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]-N-[(2R)-1-amino-1-oxopropan-2-yl]pyrrolidine-2-carboxamide

InChIKey

SBNPWPIBESPSIF-MHWMIDJBSA-N

SMILES

C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCCNC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C

Synonyms (18)
  • Cetrorelix (INN)
  • Cetrorelixum [INN-Latin]
  • Antide acetate salt
  • Cetrelix Acetate
  • Cetrorelix
  • Cetrorelixum
  • Cetrotide
  • Cetrotide (TN)
  • SB 75

Sourcing Cetrorelix?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→